• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症联合免疫缺陷小鼠中的肺泡蛋白沉积症

Pulmonary alveolar proteinosis in SCID mice.

作者信息

Jennings V M, Dillehay D L, Webb S K, Brown L A

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Am J Respir Cell Mol Biol. 1995 Sep;13(3):297-306. doi: 10.1165/ajrcmb.13.3.7654386.

DOI:10.1165/ajrcmb.13.3.7654386
PMID:7654386
Abstract

Pulmonary alveolar proteinosis (PAP) is an uncommon disorder of unknown origin in which the alveoli are filled with lipoproteinaceous material, including surfactant. We have characterized a spontaneously occurring lesion in the lungs of CB.17 scid/scid mice which resembles PAP in humans. Lungs from 45 severe combined immunodeficient (SCID) mice were evaluated by light and electron microscopy and immunohistochemistry. Lung lavage fluid was evaluated biochemically and for the presence of surfactant protein A (SP-A) and B (SP-B) by enzyme-linked immunosorbent assay and Western blot. Light microscopy showed varying amounts of a homogeneous to granular proteinaceous material in alveolar spaces. This material was eosinophilic by hematoxylin and eosin stain and was periodic acid-Schiff (PAS) positive. Ultrastructurally, the material was predominantly homogeneous with areas of a lamellated pattern that resembled surfactant. Biochemical analysis revealed 2.7- and 3.6-fold increases in the surfactant-associated phospholipids phosphatidylcholine and disaturated phosphatidylcholine respectively, when affected SCID mice were compared with control mice. Immunohistochemical staining of lung tissue and Western blot and enzyme-linked immunosorbent assay of lavage fluid showed marked increases in SP-A and SP-B in comparison with controls. These results suggest that SCID mice have a defect in surfactant homeostasis that resembles PAP in humans and may serve as an animal model in further elucidating the pathogenesis of this disease.

摘要

肺泡蛋白沉积症(PAP)是一种病因不明的罕见疾病,其中肺泡充满了包括表面活性剂在内的脂蛋白物质。我们已经对CB.17 scid/scid小鼠肺部自然发生的一种病变进行了特征描述,该病变类似于人类的PAP。通过光学显微镜、电子显微镜和免疫组织化学对45只严重联合免疫缺陷(SCID)小鼠的肺部进行了评估。对肺灌洗液进行了生化评估,并通过酶联免疫吸附测定和蛋白质印迹法检测表面活性蛋白A(SP-A)和B(SP-B)的存在情况。光学显微镜显示肺泡腔内有不同数量的均匀至颗粒状蛋白质物质。苏木精-伊红染色显示该物质呈嗜酸性,过碘酸-希夫(PAS)染色呈阳性。超微结构上,该物质主要是均匀的,有类似表面活性剂的层状区域。生化分析显示,与对照小鼠相比,受影响的SCID小鼠中表面活性剂相关磷脂磷脂酰胆碱和二饱和磷脂酰胆碱分别增加了2.7倍和3.6倍。肺组织的免疫组织化学染色以及灌洗液的蛋白质印迹和酶联免疫吸附测定显示,与对照相比,SP-A和SP-B显著增加。这些结果表明,SCID小鼠存在表面活性剂稳态缺陷,类似于人类的PAP,可能作为一种动物模型用于进一步阐明该疾病的发病机制。

相似文献

1
Pulmonary alveolar proteinosis in SCID mice.重症联合免疫缺陷小鼠中的肺泡蛋白沉积症
Am J Respir Cell Mol Biol. 1995 Sep;13(3):297-306. doi: 10.1165/ajrcmb.13.3.7654386.
2
Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.肺泡蛋白沉积症患者支气管肺泡灌洗液中表面活性蛋白A的浓度
Chest. 1993 Feb;103(2):496-9. doi: 10.1378/chest.103.2.496.
3
Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.表面活性物质蛋白A在肺泡蛋白沉积症患者肺泡中的蓄积:寡聚体结构及其与脂质的相互作用。
Am J Respir Cell Mol Biol. 1996 Jun;14(6):608-19. doi: 10.1165/ajrcmb.14.6.8652189.
4
Surfactant proteins in pulmonary alveolar proteinosis in adults.成人肺泡蛋白沉积症中的表面活性物质蛋白
Eur Respir J. 2004 Sep;24(3):426-35. doi: 10.1183/09031936.04.00076403.
5
Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage.肺泡蛋白沉积症中的支气管肺泡灌洗液体成分。治疗性灌洗后的早期变化。
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):817-20. doi: 10.1164/ajrccm.154.3.8810625.
6
Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.卡氏肺孢子虫肺炎会改变肺凝集素SP-A和SP-D的表达及分布。
J Lab Clin Med. 2001 Jun;137(6):429-39. doi: 10.1067/mlc.2001.115220.
7
Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.肺泡蛋白沉积症中表面活性蛋白(SP)-A、SP-D和KL-6免疫定位的差异
Pathol Int. 2008 Mar;58(3):203-7. doi: 10.1111/j.1440-1827.2007.02212.x.
8
Analysis of fused-membrane structures in bronchoalveolar lavage fluid from patients with alveolar proteinosis.肺泡蛋白沉积症患者支气管肺泡灌洗 fluid 中融合膜结构的分析。 注:这里“fluid”常见释义为“液体”,在医学语境中结合“支气管肺泡灌洗”推测可能是“灌洗液”,但原英文文本表述不太完整准确。
Am J Respir Cell Mol Biol. 1995 Feb;12(2):238-49. doi: 10.1165/ajrcmb.12.2.7865222.
9
Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.来自过表达表面活性物质蛋白A的小鼠的正常表面活性物质池大小和抗抑制表面活性物质
Am J Respir Cell Mol Biol. 1999 Sep;21(3):380-7. doi: 10.1165/ajrcmb.21.3.3676.
10
[Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis].[肺表面活性物质代谢先天性缺陷的临床、生物学和遗传异质性:SP-B缺乏与肺泡蛋白沉积症]
Ann Biol Clin (Paris). 2001 Mar-Apr;59(2):131-48.

引用本文的文献

1
T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung.T细胞限制性T-bet过表达诱导髓系细胞异常造血并损害肺巨噬细胞功能。
Blood. 2015 Jan 8;125(2):370-82. doi: 10.1182/blood-2014-05-575225. Epub 2014 Oct 27.
2
The molecular basis of pulmonary alveolar proteinosis.肺气泡蛋白质沉积症的分子基础。
Clin Immunol. 2010 May;135(2):223-35. doi: 10.1016/j.clim.2010.02.017. Epub 2010 Mar 25.
3
Management of pulmonary alveolar proteinosis by repeated bronchoalveolar lavage.
通过反复支气管肺泡灌洗治疗肺泡蛋白沉积症
Proc (Bayl Univ Med Cent). 2000 Apr;13(2):119-20. doi: 10.1080/08998280.2000.11927652.